Ermann, D. A., Dranitsaris, G., Blau, S., Peevyhouse, A., Neuhalfen, H., Shetty, V., Wahlstrom, S. K., Thompson, S. L., Teschemaker, A., Narkhede, M. (2025). A real-world comparative study of hypertension (HTN) and time to treatment failure (TTF) with acalabrutinib versus ibrutinib in treatment-naive Medicare-eligible patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e23279